Dediabetes Logo
Preguntas
Respuestas publicadas conectadas con evidencia
Referencia clínica
Dossieres detallados de intervenciones y resultados
Investigacion reciente
Estudios mas recientes
Acerca de
Cómo funciona deDiabetes
Configuracion
Entrar / Unirse

Glucose Variability

Ver informe de evidencia

Evidence on improving glucose variability

Evidence related to Glucose Variability.

Crea tu Evidence Workspace

Guarda evidencia sobre los temas que te importan.

43
Studies
51
Evidence Pairs
Moderate Research
Evidence Base: 66/100

Evidence guide

What does the evidence say?

Does Acarbose lower glucose-variability measures?

Acarbose may lower glucose-variability measures.

View answer

Does Basic carbohydrate counting (BCC) affect Mean amplitude of glycemic excursions (MAGE)?

Current evidence does not establish a clear direction of effect for Mean amplitude of glycemic excursions (MAGE) with Basic carbohydrate counting (BCC).

View answer

Does Exenatide lower Mean amplitude of glycemic excursions (MAGE)?

Exenatide appears to lower Mean amplitude of glycemic excursions (MAGE).

View answer
Evidence Intelligence™

Evidence Summary

A structured summary of where the evidence is strongest, mixed, or still emerging.

Executive Summary

Glucose Variability evidence appears to center on Exenatide.

Among 43 indexed studies and 36 interventions, the strongest signals are summarized from the available evidence. Hybrid closed-loop system has been studied often, while Exenatide appears to have stronger current evidence signals.

  • No strong consistent positive evidence pattern was detected.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.
Caution

This summary reflects the currently indexed evidence and should not be interpreted as treatment advice.

Key Finding

No strong consistent positive evidence pattern was detected.

Interventions with strongest consistent evidence

Strongest consistent evidence

Interpretation

The current evidence does not yet show a clear consistent-benefit pattern.

View supporting studies
Evidence basis: 2 evidence pairs - 4 studies

Why this appears here

Moderate evidenceConsistent resultsPositive effect signalMultiple RCTs
Exenatide
2 studies
EvidenceScore™
69/100
ConsistencyScore™
100/100
Sitagliptin
2 studies
EvidenceScore™
69/100
ConsistencyScore™
100/100

Evidence Snapshot

43
Studies
36
Interventions
4
Outcomes
1
Strong evidence signals
1
Mixed evidence areas

Key Findings

Key patterns and insights identified across the research landscape

Evidence signal

Hybrid closed-loop system shows evidence for Glucose variability

Hybrid closed-loop system → Glucose variability

Across 4 studies, Hybrid closed-loop system shows a evidence signal for Glucose variability.

4 studies
EvidenceScore™: 78.76923076923077/100
View supporting studies
Moderate positive signal

Acarbose may improve Coefficient of variation

Acarbose → Coefficient of variation

Across 2 studies, Acarbose shows a moderate positive signal for Coefficient of variation.

2 studies
EvidenceScore™: 69/100
View supporting studies
Moderate positive signal

Sitagliptin may improve Coefficient of variation

Sitagliptin → Coefficient of variation

Across 2 studies, Sitagliptin shows a consistent moderate positive signal for Coefficient of variation.

2 studies
EvidenceScore™: 69/100
View supporting studies
Moderate positive signal

Acarbose may improve Mean amplitude of glycemic excursions (MAGE)

Acarbose → Mean amplitude of glycemic excursions (MAGE)

Across 2 studies, Acarbose shows a consistent moderate positive signal for Mean amplitude of glycemic excursions (MAGE).

2 studies
EvidenceScore™: 69/100
View supporting studies
Neutral signal

Basic carbohydrate counting (BCC) shows limited or neutral effect on Mean amplitude of glycemic excursions (MAGE)

Basic carbohydrate counting (BCC) → Mean amplitude of glycemic excursions (MAGE)

Across 2 studies, Basic carbohydrate counting (BCC) shows a neutral signal for Mean amplitude of glycemic excursions (MAGE).

2 studies
EvidenceScore™: 69/100
View supporting studies

Supporting Evidence

Mixed or conflicting evidence

Some evidence is positive, but results are not consistent across all studies.

Areas where results are mixed

Why it matters

Mixed results suggest effects may depend on population, comparator, duration, or study design.

Interpretation

Hybrid closed-loop system is mixed in the currently indexed evidence.

Caution

Some supporting studies reported neutral, negative, or mixed findings.

Top entities

Hybrid closed-loop system
Acarbose
Hybrid closed-loop system
5 studies
EvidenceScore™
79/100
ConsistencyScore™
60/100

Why this appears here

Mixed Or Conflicting ResultsPositive Signal PresentNeutral Results Present
Evidence basis: 10 evidence pairs - 15 studies
View supporting studies
Promising but understudied

Early findings are encouraging, but stronger trials are needed.

Promising areas needing more evidence

Why it matters

Promising signals can guide further review, but they should not be treated as settled evidence.

Interpretation

Acarbose may have a beneficial signal, but the evidence base is still developing.

Caution

Current support is limited by study volume, RCT depth, or evidence strength.

Top entities

Acarbose
Exenatide
Acarbose
3 studies
EvidenceScore™
69/100
ConsistencyScore™
73/100

Why this appears here

Positive effect signalLimited study volumeFew randomized trialsEmerging Or Limited Strength
Evidence basis: 8 evidence pairs - 9 studies
View supporting studies

Explore the Evidence

The sections below provide the complete evidence questions, supporting relationships, and underlying studies behind the summary above.

Preguntas respondidas por la evidencia

Which interventions have evidence across glucose-variability measures?

Acarbose, Basic carbohydrate counting (BCC), and Exenatide are among the most studied approaches for glucose-variability measures.

Emerging Evidence · Consistency cannot yet be determined from the available evidence. · 43 studies · 43 RCTs

View top evidence signals ↓
  1. Hybrid closed-loop system · Strong · 5 studies
  2. Exenatide · Moderate · 2 studies
  3. Acarbose · Moderate · 3 studies

Acarbose vs Basic carbohydrate counting (BCC) for glucose-variability measures?

Acarbose and Basic carbohydrate counting (BCC) have available evidence for glucose-variability measures, but the comparison requires review of the underlying studies.

Moderate Evidence · Results are mixed and should be interpreted cautiously. · 5 studies · 5 RCTs

Some evidence reported benefits while other evidence found little or no effect.

View top evidence signals ↓
  1. Acarbose · Moderate · 3 studies
  2. Basic carbohydrate counting (BCC) · Moderate · 2 studies
Browse all questions about Glucose Variability

Overall Evidence Signals

Among 43 indexed studies and 36 interventions, the strongest signals are summarized from the available evidence. Hybrid closed-loop system has been studied often, while Exenatide appears to have stronger current evidence signals.

  • No strong consistent positive evidence pattern was detected.
  • Some evidence is positive, but results are not consistent across all studies.
  • Early findings are encouraging, but stronger trials are needed.

Evidence Relationships

Explore the intervention-outcome relationships with the strongest supporting evidence for Glucose Variability.

1 strong relationship, ranked by available evidence

Select any relationship to review its supporting studies.

Supporting Research

Selected studies that best represent the evidence behind this topic.

Click any study to view the full research summary, or click interventions and outcomes to filter Evidence Explorer.

Continue exploring

Related evidence briefs

Glycemic Control

Evidence Tracker

Track Glucose Variability evidence

Save this evidence topic and revisit it as new studies are added.